Disease overview

Calliditas is focused on the development and commercialization of its lead product candidate Nefecon.

Read more

Nefecon

A potential treatment for patients with IgA nephropathy at risk of developing ESRD.

Read more

Partnering

Find out more about potential partnering opportunities.

Read more

Latest events

Jan 09, 2018 Annual J.P. Morgan Healthcare Conference Day 1 - San Francisco, US
Jan 10, 2018 Annual J.P. Morgan Healthcare Conference Day 2 - San Francisco, US
Jan 11, 2018 Annual J.P. Morgan Healthcare Conference Day 3 - San Francisco, US
Jan 12, 2018 Annual J.P. Morgan Healthcare Conference Day 4 - San Francisco, US
Read more